Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial The two regimens were equitoxic and well tolerated ...
Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: Efficacy results with a median follow-up of 4 years No significant financial relationships to disclose. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results